Overall market sentiment has been down on Fortress Biotech Inc (FBIO) stock lately. FBIO receives a Bearish rating from InvestorsObserver Stock Sentiment Indicator.
Fortress Biotech Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on FBIO!
Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score.
As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend.
Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish.
InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion.
For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.
What's Happening With FBIO Stock Today?
Fortress Biotech Inc (FBIO) stock has fallen -37.07% while the S&P 500 is higher by 1.24% as of 1:39 PM on Friday, Nov 10. FBIO is down -$0.77 from the previous closing price of $2.08 on volume of 880,567 shares. Over the past year the S&P 500 is higher by 17.41% while FBIO is down -88.64%. FBIO lost -$15.12 per share in the over the last 12 months.
To see InvestorsObserver's Sentiment Score for Fortress Biotech Inc click here.
More About Fortress Biotech Inc
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Targadox, Exelderm, Ceracade, Luxamend, and Dermasorb. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.
Click Here to get the full Stock Report for Fortress Biotech Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
